Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
- Status
- TERMINATED
- Phase
- PHASE2
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Selumetinib in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Investigation of the Cylex® ImmuKnow® Assay
- Status
- COMPLETED
- Phase
- N/A
A Phase I Trial of Alloreactive Cell Infusion Following Transplantation of Haplotype Cells in Patients With Myeloid Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Trial of Bevacizumab in Myelodysplastic Syndromes (Int-1, Int-2 and High Risk According to International Prognostic Scoring System (IPSS)) With Excess of Marrow Blasts
- Status
- TERMINATED
- Phase
- PHASE2
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron Overload
- Status
- COMPLETED
- Phase
- PHASE4
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
- Status
- COMPLETED
- Phase
- PHASE2
AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders
- Status
- COMPLETED
- Phase
- NA
Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- NA